1. Home
  2. TRTX vs DAWN Comparison

TRTX vs DAWN Comparison

Compare TRTX & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRTX
  • DAWN
  • Stock Information
  • Founded
  • TRTX 2014
  • DAWN 2018
  • Country
  • TRTX United States
  • DAWN United States
  • Employees
  • TRTX N/A
  • DAWN N/A
  • Industry
  • TRTX Real Estate Investment Trusts
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRTX Real Estate
  • DAWN Health Care
  • Exchange
  • TRTX Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • TRTX 632.5M
  • DAWN 624.8M
  • IPO Year
  • TRTX 2017
  • DAWN 2021
  • Fundamental
  • Price
  • TRTX $9.10
  • DAWN $6.75
  • Analyst Decision
  • TRTX Buy
  • DAWN Strong Buy
  • Analyst Count
  • TRTX 3
  • DAWN 7
  • Target Price
  • TRTX $9.67
  • DAWN $27.86
  • AVG Volume (30 Days)
  • TRTX 603.3K
  • DAWN 2.1M
  • Earning Date
  • TRTX 07-29-2025
  • DAWN 08-05-2025
  • Dividend Yield
  • TRTX 10.55%
  • DAWN N/A
  • EPS Growth
  • TRTX N/A
  • DAWN N/A
  • EPS
  • TRTX 0.65
  • DAWN N/A
  • Revenue
  • TRTX $138,587,000.00
  • DAWN $187,638,000.00
  • Revenue This Year
  • TRTX N/A
  • DAWN $16.42
  • Revenue Next Year
  • TRTX $5.79
  • DAWN $47.52
  • P/E Ratio
  • TRTX $14.00
  • DAWN N/A
  • Revenue Growth
  • TRTX 216.02
  • DAWN 2190.50
  • 52 Week Low
  • TRTX $6.47
  • DAWN $5.64
  • 52 Week High
  • TRTX $9.32
  • DAWN $16.76
  • Technical
  • Relative Strength Index (RSI)
  • TRTX 66.63
  • DAWN 54.42
  • Support Level
  • TRTX $9.00
  • DAWN $6.08
  • Resistance Level
  • TRTX $9.19
  • DAWN $6.42
  • Average True Range (ATR)
  • TRTX 0.17
  • DAWN 0.32
  • MACD
  • TRTX 0.02
  • DAWN -0.01
  • Stochastic Oscillator
  • TRTX 89.10
  • DAWN 72.40

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: